Repligen Corp Share Price Today: Live Updates & Key Insights

Repligen Corp share price today is $113.5, up -3.17%. The stock opened at $116.0359 against the previous close of $117.61, with an intraday high of $116.7 and low of $113.65.

Repligen Corp Share Price Chart

Repligen Corp

us-stock
To Invest in {{usstockname}}
us-stock

Repligen Corp Share Price Performance

$113.5 -0.0317(-3.17%) RGEN at 23 Mar 2026 03:01 PM Medical Instruments & Supplies
Lowest Today 113.65
Highest Today 116.7
Today’s Open 116.0359
Prev. Close 117.61
52 Week High 175.77
52 Week Low 102.97
Day’s Range: Low 113.65 High 116.7
52-Week Range: Low 102.97 High 175.77
1 day return -
1 Week return -1.17
1 month return -16.08
3 month return -31.2
6 month return -9.63
1 year return -21.62
3 year return -31.44
5 year return -45.11
10 year return -

Repligen Corp Institutional Holdings

BlackRock Inc 10.90

Vanguard Group Inc 8.87

T. Rowe Price Associates, Inc. 6.23

FMR Inc 5.09

United Capital Financial Advisers Inc 4.92

State Street Corp 3.20

iShares Core S&P Mid-Cap ETF 3.04

Vanguard Total Stock Mkt Idx Inv 3.00

Point72 Asset Management, L.P. 2.56

Citadel Advisors Llc 2.48

Bank of New York Mellon Corp 2.34

Massachusetts Financial Services Company 2.16

Vanguard Small Cap Index 2.15

AllianceBernstein L.P. 1.96

RTW INVESTMENTS, LLC 1.89

Conestoga Capital Advisors, LLC 1.88

Geode Capital Management, LLC 1.83

Champlain Investment Partners, LLC 1.78

Holocene Advisors, LP 1.71

US Small-Cap Growth II Equity Comp 1.66

T. Rowe Price New Horizons 1.66

Fred Alger Management, LLC 1.62

Amvescap Plc. 1.55

MFS Mid Cap Growth A 1.54

MFS Mid Cap Growth Equity 1.46

Dimensional Fund Advisors, Inc. 1.43

BlackRock Mid-Cap Growth Equity Instl 1.34

T. Rowe Price All-Cap Opportunities Fund 1.33

T. Rowe Price US All-Cap Opp Eq Comp 1.33

Congress Asset Management Company, LLP 1.32

Vanguard Small Cap Growth Index Inv 1.19

Vanguard Institutional Extnd Mkt Idx Tr 1.01

Champlain Mid Cap Fund, LLC 0.94

Conestoga Small Cap Investors 0.89

Fidelity Select Medical Tech and Devcs 0.89

First Trust NYSE Arca Biotech ETF 0.87

T. Rowe Price New Horizons Tr-A 0.73

Fidelity Select Health Care 0.71

iShares Biotechnology ETF 0.71

Stephens SMID Select Growth 0.70

Repligen Corp Market Status

Strong Buy: 10

Buy: 4

Hold: 5

Sell: 0

Strong Sell: 0

Repligen Corp Fundamentals

Market Cap 6414.99 M

PB Ratio 3.1456

PE Ratio 132.4186

Enterprise Value 6547.42 M

Total Assets 2949.70 M

Volume 938670

Repligen Corp Company Financials

Annual Revenue FY25:738256000 738.3M, FY24:632362000 632.4M, FY23:669783000 669.8M, FY22:801536000 801.5M, FY21:670534000 670.5M

Annual Profit FY25:347624000 347.6M, FY24:308826000 308.8M, FY23:313297000 313.3M, FY22:455706000 455.7M, FY21:391254000 391.3M

Annual Net worth FY25:48894000 48.9M, FY24:35596000 35.6M, FY23:115794000 115.8M, FY22:185959000 186.0M, FY21:128291000 128.3M

Quarterly Revenue Q4/2025:197913000 197.9M, Q3/2025:188805000 188.8M, Q2/2025:182366000 182.4M, Q1/2025:169172000 169.2M, Q3/2024:154871000 154.9M

Quarterly Profit Q4/2025:93443000 93.4M, Q3/2025:100515000 100.5M, Q2/2025:91142000 91.1M, Q1/2025:90757000 90.8M, Q3/2024:77488000 77.5M

Quarterly Net worth Q4/2025:13287000 13.3M, Q3/2025:14911000 14.9M, Q2/2025:14866000 14.9M, Q1/2025:5830000 5.8M, Q3/2024:-654000 -0.7M

About Repligen Corp & investment objective

Company Information Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Organisation Medical Instruments & Supplies

Employees 2000

Industry Medical Instruments & Supplies

CEO Mr. Olivier Loeillot

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Repligen Corp FAQs

What is the share price of Repligen Corp today?

The current share price of Repligen Corp is $113.5.

Can I buy Repligen Corp shares in India?

Yes, Indian investors can buy Repligen Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Repligen Corp shares in India?

You can easily invest in Repligen Corp shares from India by:

Can I buy fractional shares of Repligen Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Repligen Corp?

Repligen Corp has a market cap of $6414.99 M.

In which sector does Repligen Corp belong?

Repligen Corp operates in the Medical Instruments & Supplies sector.

What documents are required to invest in Repligen Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Repligen Corp?

The PE ratio of Repligen Corp is 132.42 and the PB ratio is 3.15.